TEVERELIX -TFA COMPOSITION
The present invention relates to a teverelix-TFA composition having a molar ratio of teverelix to trifluoroacetate composition of at least 1:2.2. Such a molar ratio will prevent undesirable gel-formation and provide a homogenous suspension, whereby a unique bioavailablity of teverelix is obtained.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
05.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!